New data indicates that retatrutide, a novel medication, could represent a significant advance in size loss . This treatment combines the actions of a GLP-1 analog and a GIP analog, seemingly offering a greater outcome than existing approaches . Patient trials have demonstrated encouraging findings , including substantial declines in weight and… Read More